These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30523623)

  • 1. Human Papillomavirus Infection and Cervical Cancer in HIV+ Women.
    Du P
    Cancer Treat Res; 2019; 177():105-129. PubMed ID: 30523623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of HIV mRNA in routine liquid-based cytology specimens of HIV-infected women.
    Brito MJ; Quintas A; Sequeira P; Alves AT; Martins C; Félix A
    Cytopathology; 2021 Sep; 32(5):640-645. PubMed ID: 33914385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk human papillomavirus genotypes in cervical lesions and vaccination challenges in China.
    Xu QX; Zhang ZY
    Asian Pac J Cancer Prev; 2015; 16(6):2193-7. PubMed ID: 25824736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART.
    Madeddu G; Mameli G; Capobianco G; Babudieri S; Maida I; Bagella P; Rocca G; Cherchi PL; Sechi LA; Zanetti S; Nunnari G; Dessole S; Mura MS
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1277-85. PubMed ID: 24817305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening of HPV vaccinated populations: Cytology, molecular testing, both or none.
    El-Zein M; Richardson L; Franco EL
    J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S62-S68. PubMed ID: 26631958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.
    Harris TG; Burk RD; Palefsky JM; Massad LS; Bang JY; Anastos K; Minkoff H; Hall CB; Bacon MC; Levine AM; Watts DH; Silverberg MJ; Xue X; Melnick SL; Strickler HD
    JAMA; 2005 Mar; 293(12):1471-6. PubMed ID: 15784870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
    Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
    Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of human papillomavirus infection & cervical abnormalities in HIV-positive women in eastern India.
    Chakravarty J; Chourasia A; Thakur M; Singh AK; Sundar S; Agrawal NR
    Indian J Med Res; 2016 Jan; 143(1):79-86. PubMed ID: 26997018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.
    Reddy D; Njala J; Stocker P; Schooley A; Flores M; Tseng CH; Pfaff C; Jansen P; Mitsuyasu RT; Hoffman RM
    Int J STD AIDS; 2015 May; 26(6):379-87. PubMed ID: 24928579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CITRUS, cervical cancer screening trial by randomization of HPV testing intervention for upcoming screening: Design, methods and baseline data of 18,471 women.
    Morisada T; Teramoto K; Takano H; Sakamoto I; Nishio H; Iwata T; Hashi A; Katoh R; Okamoto A; Sasaki H; Nakatani E; Teramukai S; Aoki D
    Cancer Epidemiol; 2017 Oct; 50(Pt A):60-67. PubMed ID: 28818742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 15. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).
    Poljak M; Šterbenc A; Lunar MM
    Expert Rev Anti Infect Ther; 2017 Nov; 15(11):987-999. PubMed ID: 29027811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
    Gilham C; Sargent A; Kitchener HC; Peto J
    Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
    Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
    J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia.
    Schlecht NF; Kulaga S; Robitaille J; Ferreira S; Santos M; Miyamura RA; Duarte-Franco E; Rohan TE; Ferenczy A; Villa LL; Franco EL
    JAMA; 2001 Dec; 286(24):3106-14. PubMed ID: 11754676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalent and persistent oncogenic HPV types in a cohort of women living with HIV prior to HPV vaccination.
    McClymont E; Lee M; Raboud J; Coutlée F; Walmsley S; Lipsky N; Loutfy M; Trottier S; Smaill F; Klein MB; Harris M; Cohen J; Yudin MH; Wobeser W; Money D
    Int J Gynaecol Obstet; 2020 Jul; 150(1):108-115. PubMed ID: 32342504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.